Skip to main content
Clinical Trials/ACTRN12609000717257
ACTRN12609000717257
Recruiting
Phase 3

Acute cognitive, cardiovascular and stress effects of Bacopa Monniera on healthy older human participants.

Swinburne University0 sites32 target enrollmentAugust 21, 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Cognitive function in healthy older individuals
Sponsor
Swinburne University
Enrollment
32
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 21, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Swinburne University

Eligibility Criteria

Inclusion Criteria

  • Free from psychiatric disorders
  • \- No neurological diseases
  • \- Not suffering from endocrine, gastrointestinal or bleeding disorders
  • \- No history of chronic illness/infection
  • \- Not currently pregnant or lactating
  • \- Must not be taking anticoagulants, antidepressants, antipsychotics, anxiolytics, acetylcholine esterase (AChE) inhibitors, anti\-Parkinson’s medication, illicit drugs or any cognitive enhancing drugs
  • \- Must have corrected to normal vision
  • \- Non smoker

Exclusion Criteria

  • \- Psychiatric disorder
  • \- Neurological diseases
  • \- Suffering from endocrine, gastrointestinal or bleeding disorders
  • \- A history of chronic illness/infection
  • \- Pregnant or lactating
  • \- Taking anticoagulants, antidepressants, antipsychotics, anxiolytics, AChE inhibitors, anti\-Parkinson’s medication, illicit drugs or any cognitive enhancing drugs
  • \- Vision that is not normal or corrected to normal

Outcomes

Primary Outcomes

Not specified

Similar Trials